ABC | Volume 110, Nº3, Março 2018

Artigo Original Almeida Junior et al BNP, eco e avaliação clínica na insuficiência cardíaca Arq Bras Cardiol. 2018; 110(3):270-277 16. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Chamber Quantification Writing Group; American Society of Echocardiography’sGuidelinesandStandardsCommitteeEuropeanAssociation of Echocardiography. Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunctionwiththeEuropeanAssociationofEchocardiography,abranchofthe EuropeanSocietyofCardiology.JAmSocEchocardiogr.2005;18(12):1440-63. doi: https://doi.org/10.1016/j.echo.2005.10.005 17. Butman SM, Ewy GA, Standen JR, Kern KB, Hahn E. Bedside cardiovascular examination in patients with severe chronic heart failure: importance of rest or inducible jugular venous distension. J AmColl Cardiol. 1993;22(4):968- 74. https://doi.org/10.1016/0735-1097 (93)90405-P. 18. Vinayak AG, Levitt J, Gehlbach B, Pohlman AS, Hall JB, Kress JP. Usefulness of the External Jugular Vein Examination inDetecting Abnormal Central Venous Pressure in Critically Ill Patients. Arch Intern Med. 2006;166(19):2132-37. doi: 10.1001/archinte.166.19.2132. 19. Drazner MH, HamiltonMA, FonarowG, Creaser J, Flavell C, Stevenson LW. Relationship between right and left-sided filling pressures in 1000 patients with advanced heart failure. J Heart Lung Transplant. 1999;18(11):1126-32. doi: https://doi.org/10.1016/S1053-2498 (99)00070-4. 20. Drazner MH, Rame JE, Stevenson LW, Dries DL. Prognostic importance of elevated jugularvenouspressureandathirdheartsound inpatientswithheart failure. N Engl J Med. 2001;345(8):574-81. doi: 10.1056/NEJMoa010641. 21. LeierCV,ChatterjeeK.Thephysicalexaminationinheartfailure-partI.Congest Heart Fail. 2007;13(1):41-7. doi: 10.1111/j.1527-5299.2007.06409.x. 22. Leier CV, Young JB, Levine TB, Pina I, Armstrong PW, Fowler MB, et al. Nuggets, pearls, and vignettes of master heart failure clinicians. Part 2-the physical examination. Congest Heart Fail. 2001;7(6):297-308. doi: 10.1111/j.1527-5299.2001.01167.x. 23. Drazner MH, Prasad A, Ayers C, MarkhamDW, Hastings J, Bhella PS, et al. The relationship of right- and left-sided filling pressures in patients with heart failure andapreservedejectionfraction.CircHeartFail.2010;3(2):202-6.doi:10.1161/ CIRCHEARTFAILURE.108.876649.Erratum in:CircHeartFail.2012;5(1):e17. 24. Leier CV. Examining the jugular vein is never in vain. Circ Heart Fail. 2010;3(2):175-7. doi: 10.1161/CIRCHEARTFAILURE.110.944116. 25. Collins SP, PeacockWF, Lindsell CJ, Clopton P, Diercks DB, Hiestand B, et al. S3 detection as a diagnostic and prognostic aid in emergency department patients with acute dyspnea. Ann Emerg Med. 2009;53(6):748-57. doi: 10.1016/j.annemergmed.2008.12.029. 26. Marcus GM, Gerber IL, McKeown BH, Vessey JC, Jordan MV, Huddleston M, et al. Association between phonocardiographic third and fourth heart sounds and objective measures of left ventricular function. JAMA. 2005;293(18):2238-44. doi:10.1001/jama.293.18.2238. 27. Marcus G, Vessey J, Jordan MV, Huddleston M, McCkeown B, Gerber IL, et al. Relationship between accurate auscultation of a clinically useful third heart sound and level of experience. Arch InternMed. 2006;166(6):617-22. doi: 10.1001/archinte.166.6.617. 28. Sauer J, Rabelo ER, Castro RA, Goldraich L, Rohde LE, Clausell N, et al. Nurse’s performance in classifying heart failure patients based on physical exam: comparisonwith cardiologist’s physical examand levels of n-terminal pro-B-type natriuretic peptide. J Clin Nurs. 2010;19(23-24):3381-9. doi: 10.1111/j.1365-2702.2010.03403.x. 29. Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, et al; BreathingNotProperlyMultinationalStudyInvestigators.Rapidmeasurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;347(3):161-7. doi: 10.1056/NEJMoa020233. 30. Fonarow GC, Peacock WF, Phillips CO, Givertz MM, Lopatin M; ADHERE Scientific Advisory Committee and Investigators. Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure. J Am Coll Cardiol. 2007;49(19):1943-50. doi: https://doi. org/10.1016/j.jacc.2007.02.037. 31. Maisel A, Hollander JE, Guss D, McCullough P, Nowak R, Green G, et al; Rapid Emergency Department Heart Failure Outpatient Trial investigators. Primary results of the Rapid Emergency Department Heart Failure OutpatientTrial (REDHOT).AmulticenterstudyofB-typenatriureticpeptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath. J AmColl Cardiol. 2004;44(6):1328-33. doi: https://doi.org/10.1016/j.jacc.2004.06.015. 32. Drazner MH, Hellkamp AS, Leier CV, Shah MR, Miller LW, Russell SD, et al. Value of clinical assessment of hemodynamics in advanced heart failure: the ESCAPE Trial. Circ Heart Fail. 2008;1(3):170-7. doi: 10.1161/ CIRCHEARTFAILURE.108.769778. 33. Forfia PR, Watkins SP, Rame E, Stewart KJ, Shapiro EP. Relationship between B-type natriuretic peptides and pulmonary capillary wedge pressure in the intensive care unit. J AmColl Cardiol. 2005;45(10):1667-71. doi: 10.1016/j. jacc.2005.01.046. 34. Kazanegra R, Cheng V, Garcia A, Krishnaswamy P, Gardetto N, Clopton P, et al. A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study. J Card Fail. 2001;7(1):21-9. doi: 10.1054/jcaf.2001.23355. 35. Pfisterer M, Buser P, Rickli H, Gutmann M, Erne P, Rickenbacher P, et al; TIME-CHF Investigators. BNP-guided VS symptom guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly PatientsWithCongestiveHeart Failure (TIME-CHF) randomized trial. JAMA. 2009;301(4):383-92. doi: 10.1001/jama.2009.2. 36. Januzzi Jr JL,RehmanSU,MohammedAA,BhardwajA,BarajasL,Barajas J,et al. Use of amino-terminal Pro–B-Type natriuretic peptide to guide outpatient therapy of patients with chronic left ventricular systolic dysfunction. J Am Coll Cardiol. 2011;58(18):1881-9. doi: 10.1016/j.jacc.2011.03.072. 37. Collins SP, Lindsell CJ, PeacockWF, Hedger VD, Askew J, Eckert DC, et al. The combined utility of an S3 heart sound and B-type natriuretic peptide levels in emergency department patients with dyspnea. J Card Fail. 2006;12(4):286- 92. doi: 10.1016/j.cardfail.2006.01.012. 38. Temporelli PL, Scapellato F, Eleuteri E, Imparato A, Giannuzzi P. Doppler echocardiography in advanced systolic heart failure, a noninvasive alternative to Swan-Ganz catheter. Circ Heart Fail. 2010;3(3):387-94. doi: 10.1161/CIRCHEARTFAILURE.108.809590. 39. Nagueh SF, Bhatt R, Vivo RP, Krim SR, Sarvari SI, Russell K, et al. Echocardiographic evaluation of hemodynamics in patients with decompensated systolic heart failure. Circ Cardiovasc Imaging. 2011;4(3):220-7. doi: 10.1161/CIRCIMAGING.111.963496. 40. Stein JH, Neumann A, Preston LM, ConstanzoMR, Parrillo JE, JohnsonMR, et al.Echocardiographicforhemodynamicassessmentofpatientswithadvanced heart failure and potential heart transplant recipients. J Am Coll Cardiol. 1997;30(7):1765-72. doi: https://doi.org/10.1016/S0735-1097 (97)00384-7. Este um artigo de acesso aberto distribuído sob os termos da licen a de atribui ão pelo Creative Commons 277